Position in CCCC
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$15,775,171
+$5,770,804 QoQ
Shares Held
3,377,981
-11.2% QoQ
Ownership
2.75%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#13
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CCCC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. CCCC ranks #30 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
939,254 | $349,092,534 | |
| 2 | CELC |
Celcuity Inc.
|
1,704,318 | $178,305,749 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
2,927,895 | $160,858,551 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
1,843,504 | $72,117,876 | |
| 5 | VCEL |
Vericel Corp
|
1,459,152 | $64,917,672 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
177,517 | $59,430,916 | |
| 7 | GERN |
Geron Corp
|
42,808,659 | $54,795,083 | |
| 8 | ERAS |
Erasca, Inc.
|
2,700,000 | $49,464,000 |
All Filings in CCCC
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,775,171 | 3,377,981 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $10,004,367 | 3,803,942 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,265,529 | 3,803,942 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $15,659,751 | 7,053,942 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,979,887 | 6,978,942 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $11,166,307 | 6,978,942 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $25,124,191 | 6,978,942 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,642,777 | 6,603,996 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $18,720,221 | 4,051,996 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,089,997 | 2,458,996 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $10,373,377 | 1,835,996 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,007,157 | 2,692,020 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,403,055 | 2,692,020 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,495,242 | 2,387,020 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,400,973 | 2,440,843 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,642,069 | 1,441,513 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,131,105 | 282,640 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,045,015 | 166,736 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,068,128 | 561,122 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $33,538,282 | 750,633 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $32,949,482 | 870,758 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $17,165,875 | 464,068 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $8,896,995 | 268,548 | Shares | Sole | 2021-04-29 | |
| No filing history on record for this holder in this stock. | ||||||